← Leaderboards
Ryan Michael Porter
Brigham And Women'S Hospital
$2,589,958
Attributed
$2,589,958
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $310.5K · FY2006–22$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,589,958 · 6
By mechanism
P20$911,930 · 1
R21$776,733 · 2
R00$725,760 · 1
F32$89,972 · 1
K99$85,563 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Towfique Raj$16,954,166
- Martha M Murray$11,108,579
- Frederick C. Wang$16,331,006
- Mark E Brezinski$10,090,152
- Michael B Brenner$54,001,662
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCartilageAnimal ModelRegenerativeTissuesChondrogenesisStem CellsDefectArticular CartilageRepairedChondrocytesMesenchymal Stem CellsDegenerative PolyarthritisJoint InjuryGenesOsteochondral TissueIn VivoInjuryStemSignal TransductionIn VitroBaseReporterFuture
Grant awards (15)
Extracellular vesicles as therapeutic vehicles for chondroprotection$310,460
P20 · FY2022 · GM · contact PI
Extracellular vesicles as therapeutic vehicles for chondroprotection$300,648
P20 · FY2021 · GM · contact PI
Extracellular vesicles as therapeutic vehicles for chondroprotection$300,822
P20 · FY2020 · GM · contact PI
Harnessing Extracellular Vesicles to Direct the Repair of Osseous Defects$163,900
R21 · FY2019 · AR · contact PI
Harnessing Extracellular Vesicles to Direct the Repair of Osseous Defects$196,680
R21 · FY2018 · AR · contact PI
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo$172,222
R21 · FY2017 · AR · contact PI
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo$15,571
R21 · FY2017 · AR · contact PI
A Transgenic Rat for Noninvasive Assessment of Chondrogenic Activity in vivo$228,360
R21 · FY2016 · AR · contact PI
Facilitating cartilage regeneration by heterogeneous progenitor cells$229,786
R00 · FY2013 · AR · contact PI
Facilitating cartilage regeneration by heterogeneous progenitor cells$246,974
R00 · FY2012 · AR · contact PI
Facilitating cartilage regeneration by heterogeneous progenitor cells$249,000
R00 · FY2011 · AR · contact PI
Facilitating cartilage regeneration by heterogeneous progenitor cells$85,563
K99 · FY2009 · AR · contact PI
Gene-activated Bone Marrow Plugs for Cartilage Repair$27,415
F32 · FY2007 · EB · contact PI
Gene-activated Bone Marrow Plugs for Cartilage Repair$18,561
F32 · FY2007 · EB · contact PI
Gene-activated Bone Marrow Plugs for Cartilage Repair$43,996
F32 · FY2006 · EB · contact PI